SCOPUS BIOPHARMA (SCPS) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 26 106 sessions, September 8, 2025 to September 11, 2026
- Largest daily move
- +300% close of August 18, 2026
- 1-year change
- +100% closing prices, September 8, 2025 to September 11, 2026
Company Description
SCOPUS BIOPHARMA (OTC: SCPS) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $12.6K.
SCPS has gained 100.0% over the past year. The last closing price was $0.0006.
For FY2022, SCOPUS BIOPHARMA reported revenue of $0 and diluted earnings per share of -$0.55.
This page collects what Stock Titan holds for SCPS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SCOPUS BIOPHARMA (SCPS) closed at $0.0006 on September 11, 2026. Over the past 12 months, the price has gained 100.0%.
SCPS Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SCOPUS BIOPHARMA has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, management. View all SCPS news →
SEC Filings
Financial Highlights
Diluted earnings per share stood at -$0.55.
Upcoming Events
Short Interest History
Short interest in SCOPUS BIOPHARMA (SCPS) currently stands at 10.5 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for SCOPUS BIOPHARMA (SCPS) currently stands at 1.9 days, down 88.7% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 97.8% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 228.4 days.
SCPS Company Profile & Sector Positioning
SCOPUS BIOPHARMA (SCPS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing SCPS often look at related companies in the same sector, including VIRPAX PHARMS INC (VRPX), Q BIOMED INC. (QBIO), BIOSTAX CORP (BTAX), EVELO BIOSCIENCES INC (EVLO), and RENOVACARE INC (RCAR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SCPS's relative position within its industry.